Preventing HIV/Aids in Drug Abusing Youth
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00680719 |
Recruitment Status
:
Completed
First Posted
: May 20, 2008
Last Update Posted
: August 5, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: IBFT /HIV prevention Behavioral: IBFT | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 111 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Preventing HIV/Aids in Tx-Resistant Drug-Abusing Youth |
Study Start Date : | June 2004 |
Actual Primary Completion Date : | June 2013 |
Actual Study Completion Date : | June 2013 |

Arm | Intervention/treatment |
---|---|
Active Comparator: 1
Family Therapy plus HIV prevention
|
Behavioral: IBFT /HIV prevention
Integrated Behavioral and Family Therapy (IBGT) with HIV prevention.
|
Active Comparator: 2
Family Therapy only.
|
Behavioral: IBFT
Integrated Behavioral and Family Therapy (IBFT).
|
- Changes in adolescent's substance use. [ Time Frame: 12 months ]
- Changes in HIV risk behaviors. [ Time Frame: 12 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 15 Years to 20 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Parents have an adolescent in the ages of 15-20 years.
- Have had contact with the adolescent on at least 40% of the past 90 days.
- Have some knowledge or evidence that the adolescent would meet DSM-IV diagnostic criteria for a substance abuse disorder.
- Adolescent has explicitly refused to attend any intake or therapy sessions.
- All parents' efforts to enter adolescent into treatment have failed, despite therapist's assistance.
- Residence in Portland vicinity.
- Sufficient residential stability to permit probable contact at follow-up. (e.g. not homeless at time of intake)
Exclusion Criteria:
- Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures.
- Adolescent has received residential drug treatment longer than a 2-week period in the past 90 days.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00680719
United States, Oregon | |
Oregon Research Institute Center for Family and Adolescent Research | |
Portland, Oregon, United States, 97205 |
Principal Investigator: | Holly B Waldron, Ph.D. | Oregon Research Institute |
Responsible Party: | Oregon Research Institute |
ClinicalTrials.gov Identifier: | NCT00680719 History of Changes |
Other Study ID Numbers: |
DA17023 |
First Posted: | May 20, 2008 Key Record Dates |
Last Update Posted: | August 5, 2014 |
Last Verified: | August 2014 |
Keywords provided by Oregon Research Institute:
substance abuse HIV risk Behavior and Mental Disorders HIV Seronegativity |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |